The Valley Desk

ArticleDiabetes, obesity & metabolismPublished

Heterogeneity of Treatment Effects Across Nine Glucose-Lowering Drug Classes in Type 2 Diabetes: Extension of the LEGEND-T2DM Network Study

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Diabetes, obesity & metabolism
Published
Subject terms
Humans; Diabetes Mellitus, Type 2; Biguanides; Sulfonylurea Compounds; Thiazolidinediones; Blood Glucose; Hypoglycemic Agents; Treatment Outcome; Cohort Studies; Aged; Middle Aged; Female
PubMed ID
42236281
PubMed Central ID
PMC13310412
Added to directory
Source checked

Report a correction or request removal